[
  {
    "ts": null,
    "headline": "Two biopharma stocks to consider outside of Moderna",
    "summary": "Moderna (MRNA) shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Kritzer also weighs in on pet drug manufacturer Zoetis (ZTS). To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
    "url": "https://finnhub.io/api/news?id=a9c231607d8860c087d294ce62ced0ce463245b6502734a3d0ee71af2620ae40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748885400,
      "headline": "Two biopharma stocks to consider outside of Moderna",
      "id": 134955043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investment Management portfolio manager Jason Kritzer shares his perspective on the pharmaceutical industry amid pushback from the Trump administration's Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Kritzer also weighs in on pet drug manufacturer Zoetis (ZTS). To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
      "url": "https://finnhub.io/api/news?id=a9c231607d8860c087d294ce62ced0ce463245b6502734a3d0ee71af2620ae40"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Ford, Cleveland-Cliffs,  Moderna, and More",
    "summary": "U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries reached last month.",
    "url": "https://finnhub.io/api/news?id=3df4bc2c2cab8b6b61d4e12e273a7bdb19d1bcb6661344148b9ef68bb6cede5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748880580,
      "headline": "Top Stock Movers Now: Ford, Cleveland-Cliffs,  Moderna, and More",
      "id": 134953011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries reached last month.",
      "url": "https://finnhub.io/api/news?id=3df4bc2c2cab8b6b61d4e12e273a7bdb19d1bcb6661344148b9ef68bb6cede5f"
    }
  },
  {
    "ts": null,
    "headline": "Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers",
    "summary": "Tesla (TSLA) sales were mixed in Europe during May. Its sales in Norway more than tripled, while sales in France, Sweden, Denmark, the Netherlands, and Spain declined. The US Food and Drug Administration (FDA) approved Moderna's (MRNA) new COVID-19 vaccine, sending the pharmaceutical giant's stock higher. DraftKings (DKNG) stock is under pressure following news that Two Sigma Advisers lowered its stake in the company and after Illinois lawmakers passed a sports-betting tax increase. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=0b64b2db27fa756bebe9b975bb34478d059f997ee00dffb7354414c4d64287cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748875135,
      "headline": "Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers",
      "id": 134941652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Tesla (TSLA) sales were mixed in Europe during May. Its sales in Norway more than tripled, while sales in France, Sweden, Denmark, the Netherlands, and Spain declined. The US Food and Drug Administration (FDA) approved Moderna's (MRNA) new COVID-19 vaccine, sending the pharmaceutical giant's stock higher. DraftKings (DKNG) stock is under pressure following news that Two Sigma Advisers lowered its stake in the company and after Illinois lawmakers passed a sports-betting tax increase. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=0b64b2db27fa756bebe9b975bb34478d059f997ee00dffb7354414c4d64287cf"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some.",
    "summary": "Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.",
    "url": "https://finnhub.io/api/news?id=3f4b97d01d3fd5b0169429000be9d5aa548686328f65a47fcb2224ddf91077ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748872140,
      "headline": "Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some.",
      "id": 134968127,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.",
      "url": "https://finnhub.io/api/news?id=3f4b97d01d3fd5b0169429000be9d5aa548686328f65a47fcb2224ddf91077ca"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine",
    "summary": "Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.",
    "url": "https://finnhub.io/api/news?id=9af8e40d7aab5951374dc5b732ad1d45a134f96e95e08d7d301bf63053302fef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748871999,
      "headline": "Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine",
      "id": 134968128,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.",
      "url": "https://finnhub.io/api/news?id=9af8e40d7aab5951374dc5b732ad1d45a134f96e95e08d7d301bf63053302fef"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful",
    "summary": "Moderna's (MRNA) new COVID vaccine approval targets a broader high-risk population. Check out why I see potential for a 25-40% share price gain in 2025.",
    "url": "https://finnhub.io/api/news?id=a2245b42648ffecfa3c2549706b165a581634cb8dab51f4a0773ae674ba9f76f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748870721,
      "headline": "Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful",
      "id": 134951391,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1677999104/image_1677999104.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna's (MRNA) new COVID vaccine approval targets a broader high-risk population. Check out why I see potential for a 25-40% share price gain in 2025.",
      "url": "https://finnhub.io/api/news?id=a2245b42648ffecfa3c2549706b165a581634cb8dab51f4a0773ae674ba9f76f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals",
    "summary": "The U.S. Food and Drug Administration (FDA) on Saturday approved Moderna, Inc.’s (NASDAQ:MRNA) mNexspike (mRNA-1283), a new vaccine against COVID-19, for all adults 65 and older and individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). “The FDA approval of our third product, mNEXSPIKE...,” said Stéphane Bancel, Chief Executive Officer of Moderna. The FDA’s approval of mNEXSPIKE is based on results from a",
    "url": "https://finnhub.io/api/news?id=7349b88af7a8bab268de95ae32ea14e2140255bd11d38a1f7713dc8d7a731153",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748867753,
      "headline": "Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals",
      "id": 134937582,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The U.S. Food and Drug Administration (FDA) on Saturday approved Moderna, Inc.’s (NASDAQ:MRNA) mNexspike (mRNA-1283), a new vaccine against COVID-19, for all adults 65 and older and individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). “The FDA approval of our third product, mNEXSPIKE...,” said Stéphane Bancel, Chief Executive Officer of Moderna. The FDA’s approval of mNEXSPIKE is based on results from a",
      "url": "https://finnhub.io/api/news?id=7349b88af7a8bab268de95ae32ea14e2140255bd11d38a1f7713dc8d7a731153"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech",
    "summary": "Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech",
    "url": "https://finnhub.io/api/news?id=cf9d46ee8556c5f1c74bcb5e180a0f0d2cadab8c85cac7f3e14f84e34809e11e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748864340,
      "headline": "Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech",
      "id": 134944363,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech",
      "url": "https://finnhub.io/api/news?id=cf9d46ee8556c5f1c74bcb5e180a0f0d2cadab8c85cac7f3e14f84e34809e11e"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Cleveland-Cliffs, Steel Dynamics, Tesla, NIO, Blueprint Medicines, Moderna, and More",
    "summary": "Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%.",
    "url": "https://finnhub.io/api/news?id=f0d5cff9f7dddb49b4e12fb413fef9046141675bddcb2e7b93d3ea0e2c339cd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748862660,
      "headline": "These Stocks Are Moving the Most Today: Cleveland-Cliffs, Steel Dynamics, Tesla, NIO, Blueprint Medicines, Moderna, and More",
      "id": 134937548,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%.",
      "url": "https://finnhub.io/api/news?id=f0d5cff9f7dddb49b4e12fb413fef9046141675bddcb2e7b93d3ea0e2c339cd9"
    }
  },
  {
    "ts": null,
    "headline": "Moderna gains as FDA nod for next-gen COVID-19 vaccine",
    "summary": "Investing.com -- Moderna (NASDAQ:MRNA) saw its shares rose nearly 5% in premarket trading Monday after the U.S. Food and Drug Administration (FDA) has approved the drugmaker’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults 65 and older, as well as individuals aged 12 to 64 with at least one underlying condition that increases their risk of severe illness.",
    "url": "https://finnhub.io/api/news?id=4c1a11b27594a80a7153c9c2941e120d24abaf2394b9ba8351c1f23fbdbe9db3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748860140,
      "headline": "Moderna gains as FDA nod for next-gen COVID-19 vaccine",
      "id": 134937584,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Moderna (NASDAQ:MRNA) saw its shares rose nearly 5% in premarket trading Monday after the U.S. Food and Drug Administration (FDA) has approved the drugmaker’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults 65 and older, as well as individuals aged 12 to 64 with at least one underlying condition that increases their risk of severe illness.",
      "url": "https://finnhub.io/api/news?id=4c1a11b27594a80a7153c9c2941e120d24abaf2394b9ba8351c1f23fbdbe9db3"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Shares Rise on FDA Approval of Covid-19 Vaccine",
    "summary": "By Denny Jacob Moderna shares were up 4.9% in premarket trading after the Food and Drug Administration approved its newest Covid-19 vaccine over the weekend. Shares were trading around...",
    "url": "https://finnhub.io/api/news?id=bad6f6c887658d0e0452376f242172ec0ebaabe2b27809ee4bb3345bc24d8a0f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748846527,
      "headline": "Moderna Shares Rise on FDA Approval of Covid-19 Vaccine",
      "id": 134935878,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "By Denny Jacob Moderna shares were up 4.9% in premarket trading after the Food and Drug Administration approved its newest Covid-19 vaccine over the weekend. Shares were trading around...",
      "url": "https://finnhub.io/api/news?id=bad6f6c887658d0e0452376f242172ec0ebaabe2b27809ee4bb3345bc24d8a0f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: FDA approves new vaccine",
    "summary": "Moderna announced that the US FDA has approved mNEXSPIKE® , a new COVID-19 vaccine.This vaccine is indicated for use in all adults 65 years of age and older, as well as in individuals 12 through 64...",
    "url": "https://finnhub.io/api/news?id=f214b006bec20e218bfc595f6e5f607664f1ffc94deaa132b67becddec9bb1b0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748835984,
      "headline": "Moderna: FDA approves new vaccine",
      "id": 134934712,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna announced that the US FDA has approved mNEXSPIKE® , a new COVID-19 vaccine.This vaccine is indicated for use in all adults 65 years of age and older, as well as in individuals 12 through 64...",
      "url": "https://finnhub.io/api/news?id=f214b006bec20e218bfc595f6e5f607664f1ffc94deaa132b67becddec9bb1b0"
    }
  }
]